Lyra Therapeutics Inc (LYRA)
NASDAQ
News
Market Data
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -47.549 | -80.879 | -46.198 | -64.133 | -67.071 | -49.634 |
| Return on Equity (%) | 11.261 | 14.154 | 90.599 | -79.981 | -96.077 | -73.666 |
| Return on Invested Capital (%) | -63.259 | -114.505 | -55.559 | -81.318 | -100.64 | -80.476 |
| Operating Margin (%) | -484.646 | N/A | N/A | -15267.719 | -4054.659 | -4019.32 |
| Net Profit Margin (%) | -484.646 | N/A | N/A | -15267.719 | -4055.613 | -4023.107 |
| Book Value Per Share | 136.935 | 31.861 | 5.76 | 2.638 | 2.537 | 1.701 |
| Earnings Per Share | -35.465 | -70.896 | -1.711 | -3.345 | -1.737 | -1.192 |
| Cash Per Share | 140.518 | 42.643 | 5.768 | 3.517 | 1.023 | 0.425 |
| Working Capital Per Share | 135.1 | 21.352 | 5.493 | 2.281 | 2.713 | 1.621 |
| Operating Profit Per Share | 7.318 | N/A | N/A | 0.022 | 0.043 | 0.03 |
| EBIT Per Share | -35.465 | -70.896 | -1.711 | -3.345 | -1.736 | -1.191 |
| EBITDA Per Share | -35.465 | -70.896 | -1.711 | -3.345 | -1.736 | -1.191 |
| Free Cash Flow Per Share | -35.729 | -70.096 | -1.581 | -3.162 | -1.765 | -1.178 |
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 170k | 230k | 12.93M | 13.01M | 31.83M | N/A |
| Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
| Shares Outstanding | 31.83M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | -3961.22 | N/A | N/A | N/A | -4217.669 | N/A | N/A |
| Net Profit Margin (%) | N/A | -3964.634 | N/A | N/A | N/A | -4220.301 | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 11.93M |
| Price to Earnings Ratio | -0.19 |
| Price to Sales Ratio | 7.56 |
| Price to Cash Ratio | 0.53 |
| Price to Book Ratio | 0.13 |
| Dividend Yield | - |
| Shares Outstanding | 65.46M |
| Average Volume (1 week) | 630.52k |
| Average Volume (1 Month) | 1.26M |
| 52 Week Change | -96.21% |
| 52 Week High | 6.79 |
| 52 Week Low | 0.1625 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
